This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsUSFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults
CDSCO Panel Opines Key Changes in Phase III Study of Glimepiride-Linagliptin FDCPure & Cure Healthcare gets CDSCO Panel nod to study Ferric Maltol Capsules 30 mg
Lupin rolls out constipation drug Prucalopride in US after USFDA nodUpcoming 50 pharma manufacturing plants under PLI scheme to be completed in 2 years: Centre
Alembic Launches First Branded Drug Pivya in US for UTI TreatmentAlembic Pharma receives USFDA EIR for Oral solid formulation facility (F-1) at Panelav
Language Row Costs Pharmacist: Action Ordered for Giving Wrong Medicine, Refusing BengaliDrugs in CDSCO samples Counterfeit, not ours, say leading pharma companies
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsUSFDA issues three observations each on API, Finished Product side of Lupin Pithampur facility
Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin AmericaLupin arm ink pact with Celnova for distribution of Orphan Drug NaMuscla in Argentina, Colombia
Pill form of Wegovy gets USFDA approval for weight lossPresent difference of approved and proposed formulation: CDSCO tells Novo Nordisk's Semaglutide...
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusAlembic Pharma receives USFDA approval for schizophrenia drug Paliperidone Extended Release
Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and BiosimilarsSun Pharma presents new clinical efficacy, safety data in severe dermatological conditions at 2024...
Wockhardt group Founder Chairman Dr Habil Khorakiwala bags Lifetime Achievement Award at 10th IHW summit in DubaiWockhardt group Founder Chairman Dr Habil Khorakiwala bags Lifetime Achievement Award at 10th IHW...
OPPI appoints Bhushan Akshikar as PresidentOPPI appoints Bhushan Akshikar as President
X